Delivery Order SPE2DB20D3103-SPE2DB23FN0Y8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,983,291 units of Naloxone HCL 4 mg Nasal Spray. The delivery order, valued at $1,845.84, has a firm fixed-price and is expected to be completed by May 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of 4,560,559,581 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The contract, valued at $3,045.39, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 12, 2023. This contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award, valued at $2,397.78, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,563,143,368 units of Naloxone HCL 4 mg Nasal Spray, with a completion date of December 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This...
- This federal contract award, valued at $1,211.88, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,450,464 units of Naloxone HCL 4 mg Nasal Spray, with an ultimate completion date of November 18, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,172,804 units of Naloxone HCl 4 mg Nasal Spray. The contract, valued at $7,397.79, is a Firm Fixed Price Delivery Order with a completion date of March 8, 2023. The contract was awarded on March 7, 2023, and there is no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,252,687 units of Naloxone HCL 4 mg nasal spray. The contract has a Firm Fixed Price (FFP) pricing type, a ceiling value of $46,516.61, and an ultimate completion date of September 21, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,559,450,602 units of Naloxone HCL 4 mg Nasal Spray. The contract is a Delivery Order with a Firm Fixed Price of $1,855.43 and a completion date of December 27, 2022. The contract was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the supply of 4,563,955,933 units of Naloxone HCl 4 mg Nasal Spray in 2-count packages, with a total ceiling value of $5,637.45 and an ultimate completion date of March 14, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,367,200 units of Naloxone HCL 4 mg Nasal Spray. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,950.71 and an ultimate completion date of August 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is for the delivery of 4,560,315,275 units of Naloxone HCL 4 mg Nasal Spray. The $2,556.39 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 21, 2023 and is not designated as a set-aside requirement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FN0Y8Delivery Order
This federal contract award, identified as SPE2DB20D3103|SPE2DB23FN0Y8, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,452.65, is for the delivery of 4,560,615,921 units of Naloxone HCl 4 mg Nasal Spray. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is April 18, 2023. The contract is not designated with any set-aside requirements, indicating full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is likely a delivery order placed against that larger IDC contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 4/17/23 |